ASHLEY CAFFERTY: Open Payments
NPI 1215001417 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 8 payments from 6 companies in 2025. Trend: 2023 $30 · 2024 $111 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $102 |
| UCB, Inc. | 3 | $63 |
| Reprise Biomedical, Inc. | 1 | $32 |
| LEO Pharma Inc. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
| REVANCE THERAPEUTICS, INC. | 1 | $15 |
Products named: Opzelura, Bimzelx, Miro3D, ADBRY, BLU-U, DAXXIFY.
Industry payments across ID — which companies pay providers there.
